Followers | 814 |
Posts | 30688 |
Boards Moderated | 5 |
Alias Born | 03/22/2016 |
![](https://investorshub.advfn.com/uicon/558887.png?cb=1697550425)
Friday, February 09, 2024 9:54:37 AM
Recent ADCT News
- ADC Therapeutics Makes Grants to New Employees Under Inducement Plan • GlobeNewswire Inc. • 07/01/2024 08:05:00 PM
- ADC Therapeutics Set to Join Russell 2000® and Russell 3000® Indexes • GlobeNewswire Inc. • 06/27/2024 11:15:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/19/2024 01:41:51 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/19/2024 01:40:13 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/19/2024 01:38:42 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/14/2024 09:40:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/14/2024 09:37:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/14/2024 09:23:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/14/2024 08:11:14 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 06/06/2024 07:33:52 PM
- ADC Therapeutics Makes Grants to New Employees Under Inducement Plan • GlobeNewswire Inc. • 06/03/2024 08:05:00 PM
- ADC Therapeutics to Participate in the Jefferies Global Healthcare Conference • GlobeNewswire Inc. • 05/30/2024 11:15:00 AM
- ADC Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ • GlobeNewswire Inc. • 05/15/2024 11:15:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 04:32:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/09/2024 08:06:52 PM
- ADC Therapeutics to Participate in 2024 RBC Capital Markets Global Healthcare Conference • GlobeNewswire Inc. • 05/09/2024 11:15:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2024 08:07:17 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/07/2024 08:06:28 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 05/07/2024 08:02:43 PM
- ADC Therapeutics Announces $105 Million Underwritten Offering of Common Shares and Pre-Funded Warrants • GlobeNewswire Inc. • 05/06/2024 11:30:00 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 05/06/2024 10:51:41 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/06/2024 10:38:11 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2024 10:29:27 AM
- ADC Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates • GlobeNewswire Inc. • 05/06/2024 10:10:00 AM
- ADC Therapeutics Announces Initial Data from Investigator-Initiated Phase 2 Clinical Trial of ZYNLONTA® in Patients with Relapsed/Refractory Marginal Zone Lymphoma • GlobeNewswire Inc. • 05/06/2024 10:00:00 AM
FEATURED Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM